News

New guidance covers recommendations on pacing device indications, pre/during/post implant evaluations, and optimization of pacing response in adults and children

The Heart Rhythm Society releases comprehensive guidance for managing arrhythmias in the pregnant patient and fetus

-REAL AF Registry uses data from over 6,000 patients to better understand procedural efficiency, safety, and long-term effectiveness of catheter ablation for atrial fibrillation (AFib) -Three abstracts selected for oral presentations, one...

-Data from two preclinical studies of investigational pulsed field ablation (PFA) products were selected for oral presentations and highlight the company’s commitment to developing a comprehensive PFA technology -New web-based resource...

Heart Rhythm 2023: Late-breaking analysis of the PULSED AF Trial reveals first of its kind significant, meaningful quality of life improvements and healthcare utilization benefits of the PulseSelect Pulsed Field Ablation System Medtronic...

International experts collaborate to issue new recommendations for remote monitoring of cardiovascular implantable electronic devices

TactiFlex™ Ablation Catheter, Sensor Enabled™, is the world's first ablation catheter designed with a unique flexible electrode tip and contact force sensing to treat patients with atrial fibrillation When used with Abbott's EnSite™ X EP...

Abbott's Assert-IQ offers the world's longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott's portfolio of connected health devices, the Assert-IQ ICM offers long-term monitoring and remote...

Advanced medical device reprocessor’s HRS poster session describes how using reprocessed devices in an Atrial Fibrillation ablation procedure can reduce device costs by more than 30% and improve an EP lab’s environmental...

Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices SILVER SPRING, Md., May 19, 2023 — Aziyo Biologics, Inc., a company that develops and commercializes...